Logo-jcvtr

J Cardiovasc Thorac Res. 2023;15(3): 154-160. doi: 10.34172/jcvtr.2023.32895
PMID: 38028718        PMCID: PMC10590464

Original Article

Plasminogen activator urokinase receptor as a diagnostic and prognostic biomarker in type 2 diabetic patients with cardiovascular disease

Melak Saleh Mohammed 1 ORCID, Hind Shakir Ahmed 1 * ORCID

Cited by CrossRef:

1- Ahmed H, Ahmed H, Abud H. The role of vitamin D against COVID-19 infection, progression and severity. HAB. 2024;32(2):51 [Crossref]
2- Hassan H, Ahmed H, Hassan D. Free radicals and oxidative stress: Mechanisms and therapeutic targets. Human Antibodies. 2024;32(4):151 [Crossref]
3- Ahmed H, Ahmed H. The potential role of dyslipidemia in COVID-19 severity among Iraqi patients. Human Antibodies. 2024;32(4):229 [Crossref]
4- Ahmed H, Abud H, Ahmed H. State of type 2 diabetic Iraqi patients after hospitalization for COVID-19. Human Antibodies. 2025;33(1-2):52 [Crossref]
5- Zhang Y, Zhou H, Liu J, Zhou N. Identification of key genes and immune infiltration of diabetic peripheral neuropathy in mice and humans based on bioinformatics analysis. Front Endocrinol. 2024;15 [Crossref]
6- Li J, Yan Y, Ouzaouit A, Wang J, Yang Z, Shi H, Peprah A, Jiang T, Lai Y. Circulating anti-nephrin antibody as permeability factor for inducing primary focal segmental glomerular sclerosis and minimal change disease. Next Research. 2025;2(2):100345 [Crossref]